These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 17086805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM, Desai A.
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [Abstract] [Full Text] [Related]

  • 5. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
    Cyriac S, Rajendranath R, Sridevi V, Sagar TG.
    J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y, Wan XR, Sun ZJ, Yang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
    [Abstract] [Full Text] [Related]

  • 15. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC, Singh DK, Rademaker AW, Miller DS, Lurain JR.
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [Abstract] [Full Text] [Related]

  • 16. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR, Brewer JI.
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of high-risk gestational trophoblastic disease.
    Lurain JR.
    J Reprod Med; 1998 Jan; 43(1):44-52. PubMed ID: 9475149
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
    Kohorn EI.
    Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.